dc.contributor.author
Crespo-Garcia, Sergio
dc.contributor.author
Reichhart, Nadine
dc.contributor.author
Skosyrski, Sergej
dc.contributor.author
Foddis, Marco
dc.contributor.author
Wu, Jim
dc.contributor.author
Figura, Aleksandar
dc.contributor.author
Herrspiegel, Christina
dc.contributor.author
Füchtemeier, Martina
dc.contributor.author
Sassi, Celeste
dc.contributor.author
Dirnagl, Ulrich
dc.contributor.author
Joussen, Antonia M.
dc.contributor.author
Strauss, Olaf
dc.date.accessioned
2019-04-18T09:06:29Z
dc.date.available
2019-04-18T09:06:29Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/24451
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-2222
dc.description.abstract
Animal models of disease are an indispensable element in our quest to understand pathophysiology and develop novel therapies. Ex vivo studies have severe limitations, in particular their inability to study individual disease progression over time. In this respect, non-invasive in vivo technologies offer multiple advantages. We here used bilateral common carotid artery occlusion (BCCAO) in mice, an established model for ischemic retinopathy, and performed a multimodal in vivo and ex vivo follow-up. We used scanning laser ophthalmoscopy (SLO), ocular coherence tomography (OCT) and electroretinography (ERG) over 6 weeks followed by ex vivo analyses. BCCAO leads to vascular remodeling with thickening of veins starting at 4 weeks, loss of photoreceptor synapses with concomitant reduced b-waves in the ERG and thinning of the retina. Mononuclear phagocytes showed fluctuation of activity over time. There was large inter-individual variation in the severity of neuronal degeneration and cellular inflammatory responses. Ex vivo analysis confirmed these variable features of vascular remodeling, neurodegeneration and inflammation. In summary, we conclude that multimodal follow-up and subgroup analysis of retinal changes in BCCAO further calls into question the use of ex vivo studies with distinct single end-points. We propose that our approach can foster the understanding of retinal disease as well as the clinical translation of emerging therapeutic strategies.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
bilateral common carotid artery occlusion (BCCAO)
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Individual and temporal variability of the retina after chronic bilateral common carotid artery occlusion (BCCAO)
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
e0193961
dcterms.bibliographicCitation.doi
10.1371/journal.pone.0193961
dcterms.bibliographicCitation.journaltitle
PLoS ONE
dcterms.bibliographicCitation.number
3
dcterms.bibliographicCitation.originalpublishername
Public Library of Science (PLoS)
dcterms.bibliographicCitation.volume
13
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.isSupplementedBy.doi
10.5281/zenodo.1095818
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
29547662
dcterms.isPartOf.issn
1932-6203